Interferon-γ (IFNγ), a double-edge sword that affects prognoses in critically ill patients: A prospective study

Guangjian Wang1, Hui Lian1, Hongmin Zhang1

  • 1Department of Health Care, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Cytokine
|January 13, 2026
PubMed
Abstract

Insights

Interferon-gamma (IFNγ) shows a strong link to multiple organ dysfunction syndrome (MODS) and survival in critically ill patients. Elevated IFNγ may predict MODS and patient outcomes, offering a valuable biomarker in critical care settings.

Area of Science:

  • Critical care medicine
  • Immunology
  • Biomarker research

Background:

  • Abnormal inflammatory responses and viral infections are key in critical illness pathogenesis.
  • Multiple organ dysfunction syndrome (MODS) significantly impacts outcomes and prognosis in critically ill patients.
  • Interferon-gamma (IFNγ), a regulatory cytokine, may indicate viral infection severity and predict MODS.

Purpose of the Study:

  • To evaluate the association between Interferon-gamma (IFNγ) levels and clinical outcomes in critically ill patients.

Main Methods:

  • Prospective study (Jan 1 - May 31, 2023) at Peking Union Medical College Hospital.
  • Data collected from electronic medical records, including baseline characteristics, ICU parameters, lab tests, and outcomes.
  • Generalized Additive Models and Kaplan-Meier survival analyses were used to assess associations.

Main Results:

  • IFNγ levels correlated positively with MODS in sepsis and non-sepsis subgroups.
  • A U-shaped curve (threshold 5.3 ng/mL) was observed between IFNγ levels and 28-day mortality.
  • Low IFNγ levels were linked to poorer prognosis in sepsis patients; procalcitonin (PCT) showed no significant prognostic difference.

Conclusions:

  • IFNγ is strongly associated with MODS and prognosis in critically ill patients.
  • IFNγ shows potential as a biomarker for predicting MODS occurrence and patient outcomes.
  • Findings support the clinical value of IFNγ in critical care and warrant further research.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
777
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
751
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
768
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
311
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
832